Myeloid cell factor–1 is a critical survival factor for multiple myeloma
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Multiple myeloma (MM) is characterized by the accumulation of malignant plasma cells in the bone marrow caused primarily by failure of normal homeostatic mechanisms to prevent the expansion of postgerminal center plasma cells. We have examined the molecular mechanisms that promote the survival of MM cells and have identified a key role for myeloid cell factor–1 (Mcl-1), an antiapoptotic member of the Bcl-2 family. These experiments were initiated by the observation that MM cells were exquisitely sensitive to culture in the presence of actinomycin D: caspase activation occurred within 3 hours of treatment and cells were not protected by interleukin-6, the main MM cell growth and survival factor. Actinomycin D–induced apoptosis was blocked by proteasome inhibitors, suggesting that a labile protein was required for MM cell survival. Further analysis demonstrated that Mcl-1 was likely to be the labile factor governing MM cell survival. Mcl-1 protein levels decreased rapidly after culture in the presence of actinomycin D in concordance with effector caspase activation, but addition of proteasome inhibitors reversed the loss of Mcl-1 and maintained cell viability. The levels of other antiapoptotic proteins, including Bcl-2 and members of the inhibitors-of-apoptosis family, were unaffected by these interventions. Furthermore, Mcl-1 antisense oligonucleotides caused a rapid down-regulation of Mcl-1 protein levels and the coincident induction of apoptosis, whereas overexpression of Mcl-1 delayed actinomycin D–induced apoptosis with kinetics that correlated with expression levels of Mcl-1. These data indicate that Mcl-1 expression is required for the survival of MM cells and may represent an important target for future therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCL-1 is validated as a target in other hematologic malignancies e.g., multiple myeloma13 and non-Hodgkins lymphoma,14 as well as diverse solid tumor malignancies, including lung cancer,15 breast cancer,16 and colon cancer,17 among others.18”
From Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
Ttal, M. I. A., Ean, J., Dünne, A. A., Toppa, A. S., Ossi, R. G., Hilippe, P., Asassus, C., Acon, T. H. F., Orbert, N., Ayen, C. A. P., et al. (2013) · Cited by 2,161
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,049
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S., Korneluk, R. G., & MacKenzie, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 982
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961
Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 901
Klein, B., Zhang, X., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., & Bataille, R. (1989) · Blood · doi:10.1182/blood.v73.2.517.517 · Cited by 763
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Hallek, M., Leif Bergsagel, P., & Anderson, K. C. (1998) · Blood · doi:10.1182/blood.v91.1.3 · Cited by 752
From bench to clinic with apoptosis-based therapeutic agents
Nicholson, D. W. (2000) · Nature · doi:10.1038/35037747 · Cited by 687
Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase
Marshall, N. F., Peng, J., Xie, Z., & Price, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27176 · Cited by 662
Bone marrow angiogenesis and progression in multiple myeloma
Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., & Dammacco, F. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08304.x · Cited by 630
Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo
Chao, S.-H., & Price, D. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102306200 · Cited by 621
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 590
Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.
Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., & Wang, H. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9238 · Cited by 586
Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.3.1104.bloodjournal8731104 · Cited by 563
Reversible Phosphorylation of the C-terminal Domain of RNA Polymerase II
Dahmus, M. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19009 · Cited by 498
Preclinical and Clinical Development of Cyclin-Dependent Kinase Modulators
Senderowicz, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.376 · Cited by 492
Martin, S. J., Lennon, S. V., Bonham, A. M., & Cotter, T. G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1859 · Cited by 483
Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication
Chao, S.-H., Fujinaga, K., Marion, J. E., Taube, R., Sausville, E. A., Senderowicz, A. M., Peterlin, B. M., & Price, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000446200 · Cited by 455
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Mcl-1 deficiency results in peri-implantation embryonic lethality
Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.1.23 · Cited by 397
Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice
Nakayama, K.-I., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., et al. (1993) · Science · doi:10.1126/science.8372353 · Cited by 397
Tricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D., Naucke, S., & Sawyer, Jr. (1995) · Blood · doi:10.1182/blood.v86.11.4250.bloodjournal86114250 · Cited by 395
Wang, J.-M., Chao, J.-R., Chen, W., Kuo, M.-L., Yen, J. J.-Y., & Yang-Yen, H.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6195 · Cited by 357
Mcl-1 Expression in Human Neutrophils: Regulation by Cytokines and Correlation With Cell Survival
Moulding, D. A., Quayle, J. A., Hart, C. A., & Edwards, S. W. (1998) · Blood · doi:10.1182/blood.v92.7.2495 · Cited by 355
Zhou, P., Qian, L., Kozopas, K. M., & Craig, R. W. (1997) · Blood · doi:10.1182/blood.v89.2.630 · Cited by 326
Woods, D. B., & Vousden, K. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5141 · Cited by 319
Yang, T., Kozopas, K. M., & Craig, R. W. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1173 · Cited by 299
Interleukin-6 Inhibits Apoptosis of Malignant Plasma Cells
Lichtenstein, A., Tu, Y., Fady, C., Vescio, R., & Berenson, J. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.1076 · Cited by 271
Kitada, S., Zapata, J. M., Andreeff, M., & Reed, J. C. (2000) · Blood · doi:10.1182/blood.v96.2.393 · Cited by 264
Interleukin-6 prevents dexamethasone-induced myeloma cell death
Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H., & Epstein, J. (1994) · Blood · doi:10.1182/blood.v84.9.3063.3063 · Cited by 262
Puthier, D., Bataille, R., & Amiot, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199912)29:12<3945::aid-immu3945>3.0.co;2-o · Cited by 254
Mechanisms of action of flavopiridol
Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00124-4 · Cited by 239
BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
Tu, Y., Renner, S., Xu, F., Fleishman, A. N., Taylor, J. M. G., Weisz, J., Vescio, R. A., Rettig, M. B., Berenson, J., Krajewski, S., et al. (1998) · PubMed · Cited by 222
Avet‐Loiseau, H., Facon, T. T. F., Daviet, A., Godon, C., Rapp, M.-J., Harousseau, J., Grosbois, B., & Bataille, R. (1999) · PubMed · Cited by 194
Yankulov, K., Yamashita, K., Roy, R., Egly, J.-M., & Bentley, D. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23922 · Cited by 191
Schwarze, M. M., & Hawley, R. G. (1995) · PubMed · Cited by 189
Zhou, P., Levy, N. B., Xie, H., Qian, L., Lee, C.-Y. G., Gascoyne, R. D., & Craig, R. W. (2001) · Blood · doi:10.1182/blood.v97.12.3902 · Cited by 186
Chao, J.-R., Wang, J.-M., Lee, S.-F., Peng, H.-W., Lin, Y.-H., Chou, C.-H., Li, J.-C., Huang, H.-M., Chou, C.-K., Kuo, M.-L., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4883 · Cited by 185
p53 and RAS gene mutations in multiple myeloma.
Portier, M., Molès, J., Mazars, G. R., Jeanteur, P., Bataille, R., Klein, B., & Theillet, C. G. (1992) · PubMed · Cited by 168
Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cells
Puthier, D., Derenne, S., Barillé, S., Moreau, P., Harousseau, J., Bataille, R., & Amiot, M. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01705.x · Cited by 157
Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells
Moulding, D. A., Giles, R. V., Spiller, D. G., White, M. R. H., Tidd, D. M., & Edwards, S. W. (2000) · Blood · doi:10.1182/blood.v96.5.1756 · Cited by 141
Loss of PTEN expression leading to high Akt activation in human multiple myelomas
Hyun, T., Yam, A., Pece, S., Xie, X., Zhang, J., Miki, T., Gutkind, J. S., & Li, W. (2000) · Blood · doi:10.1182/blood.v96.10.3560 · Cited by 127
Townsend, K. J., Zhou, P., Qian, L., Bieszczad, C. K., Lowrey, C. H., Yen, A., & Craig, R. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1801 · Cited by 123
Reynolds, J. E., Li, J., Craig, R. W., & Eastman, A. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0194 · Cited by 123
Dubois, M. F., Nguyen, V. T., Bellier, S., & Bensaude, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36837-0 · Cited by 122
PROGNOSTIC FACTORS IN MULTIPLE MYELOMA
Rajkumar, S. V., & Greipp, P. R. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70128-3 · Cited by 116
Mechanism of action of dichloro-beta-D-ribofuranosylbenzimidazole: effect on in vitro transcription.
Zandomeni, R. O., Mittleman, B. B., Bunick, D., Ackerman, S., & Weinmann, R. S. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3167 · Cited by 106
Billadeau, D. D., Jelinek, D. F., Shah, N., LeBien, T. W., & Ness, B. V. (1995) · PubMed · Cited by 104
Akgul, C., Moulding, D. A., White, M. R. H., & Edwards, S. W. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01809-3 · Cited by 98
Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes.
Lømo, J., Smeland, E. B., Krajewski, S., Reed, J. C., & Blomhoff, H. K. (1996) · PubMed · Cited by 96
Townsend, K. J., Trusty, J. L., Traupman, M. A., Eastman, A. R., & Craig, R. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202035 · Cited by 96
Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.
Klein, B. (1995) · PubMed · Cited by 95
Koumenis, C., & Giaccia, A. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7306 · Cited by 86
Interleukin-6 dependence of advanced malignant plasma cell dyscrasias
Zhang, X., Bataille, R., Widjenes, J., & Klein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920315)69:6<1373::aid-cncr2820690612>3.0.co;2-1 · Cited by 83
Bodrug, S., Aimé, C., Sato, T., Krajewski, S., Hanada, M., & Reed, J. (1995) · PubMed · Cited by 61
Puthier, D., Pellat‐Deceunynck, C., Barillé‐Nion, S., Robillard, N., Rapp, M.-J., Juge‐Morineau, N., Harousseau, J., Bataille, R., & Amiot, M. (1999) · Leukemia · doi:10.1038/sj.leu.2401302 · Cited by 57
Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo
Ge, N.-L., & Rudikoff, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203801 · Cited by 55
Wang, L. (1999) · The Journal of Membrane Biology · doi:10.1007/s002329900589 · Cited by 42
Miguel-Garcia, A., Orero, T., Matutes, E., Carbonell, F., Miguel-Sosa, A., Linares, M., Tarín, F., Herrera, M., Garcia‐Talavera, J., & Carbonell-Ramón, F. (1998) · PubMed · Cited by 40
Bcl-2 protein expression is not related to short survival in multiple myeloma.
Ong, F., van Nieuwkoop, J. A., de Groot-Swings, G. M., Hermans, J. H., Harvey, M. S., Kluin, P. M., & Kluin‐Nelemans, H. C. (1995) · PubMed · Cited by 34
MECHANISMS OF MYELOMA CELL GROWTH CONTROL
Jelinek, D. F. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70117-9 · Cited by 29
CYTOGENETIC ABNORMALITIES IN MULTIPLE MYELOMA
Fonseca, R., Coignet, L., & Dewald, G. W. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70119-2 · Cited by 25
AUTOTRANSPLANTS IN MULTIPLE MYELOMA: PUSHING THE ENVELOPE
Jagannath, S., Tricot, G. J. K., & Barlogie, B. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70436-6 · Cited by 20
THE ROLE OF ADHESION RECEPTORS IN THE PATHOGENESIS OFMULTIPLE MYELOMA
Witzig, T. E. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70116-7 · Cited by 17
Cited by
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M., & Huang, D. C. S. (2005) · Genes & Development · doi:10.1101/gad.1304105 · Cited by 1,233
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Kotschy, A., Szlavik, Z., Murray, J., Davidson, J., Maragno, A. L., Le Toumelin-Braizat, G., Chanrion, M., Kelly, G. L., Gong, J.-N., Moujalled, D. M., et al. (2016) · Nature · doi:10.1038/nature19830 · Cited by 1,047
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Ashkenazi, A., Fairbrother, W. J., Leverson, J. D., & Souers, A. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.253 · Cited by 903
Metadata
- Authors
- Zhang, B., Gojo, I., & Fenton, R. G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-03-15
- Volume
- 99
- Issue
- 6
- Pages
- 1885-1893
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2057942504
- Cited by
- 367
- References
- 83
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.